Effects of loading procedures of magnetic nanoparticles on the structure and physicochemical properties of cisplatin magnetic liposomes

References

• Ali BH, Al-Moundhri MS. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: A review of some recent research. Food Chem Toxicol 2006; 44: 1173–83
   PubMed Web of Science ®Google Scholar
• Arruebo M, Fernandez-Pacheco R, Ibarra MR. Santamaria J. Magnetic nanoparticles for drug delivery. Nano Today 2007; 2: 22–32
   Web of Science ®Google Scholar
• Bermarda R, Emmanueld G, Emmanuelb P, Guillaumee H, Delphineb D, Mariellec C, Loïcd C, Emmanuelc S, Brunof C, Brunob H, et al. Serum and intraperitoneal pharmacokinetics of cisplatin within intraoperative intraperitoneal chemotherapy: Influence of protein binding. Anti-Cancer Drugs 2005; 16: 1009–16
   PubMedGoogle Scholar
• Berry CC. Progress in functionalization of magnetic nanoparticles for applications in biomedicine. J Phys D: Appl Phys 2009; 42: 224003
   Web of Science ®Google Scholar
• Chomouck J, Drbohlavov J, Husk D, Adam V, Kizek R, Hubalek J. Magnetic nanoparticles and targeted drug delivering. Pharmacol Res 2010; 62: 144–49
   PubMedGoogle Scholar
• Chon HS, Marchion DC, Xiong Y, Chen N, Bicaku E, Stickles XB, Zgheib NB, Judson PL, Hakam A, Gonzalez-Bosquet J, et al. The BCL2 antagonist of cell death pathway influences endometrial cancer cell sensitivity to cisplatin. Gynecol Oncol 2012; 124: 119–24
   PubMedGoogle Scholar
• Giri J, Thakurta SG, Bellare J, Nigamc AK, Bahadur D. Preparation and characterization of phospholipid stabilized uniform sized magnetite nanoparticles. J Magn Magn Mater 2005; 293: 62–8
   Google Scholar
• Gonzales M, Krishnan KM. Synthesis of magnetoliposomes with monodisperse iron oxide nanocrystal cores for hyperthermia. J Magn Magn Mater 2005; 293: 265–70
   Web of Science ®Google Scholar
• Grabielle-Madelmont C, Lesieur S, Ollivon M. Characterization of loaded liposomes by size exclusion chromatography. J Biochem Biophys Methods 2003; 56: 189–217
   PubMedGoogle Scholar
• Kahani SA, Jafari M. A new method for preparation of magnetite from iron oxyhydroxide or iron oxide and ferrous salt in aqueous solution. J Magn Magn Mater 2009; 321: 1951–4
   Web of Science ®Google Scholar
• Katre NV, Asherman J, Schaffer H, Hora M. Multivesicularliposome (DepoFoam) technology for the sustained delivery of insulin-like growth factor-I (IGF-I). J Pharm Sci 1998; 87: 1341–6
   PubMed Web of Science ®Google Scholar
• Kim DK, Zhang Y, Voit W, Rao KV, Muhammed M. Synthesis and characterization of surfactant-coated superparamagnetic monodispersed iron oxide nanoparticles. J Magn Magn Mater 2001; 225: 30–6
   Web of Science ®Google Scholar
• Kuang Y, Liu J, Liu ZL, Zhuo RX. Cholesterol-based anionic long-circulating cisplatin liposomes with reduced renal toxicity. Biomaterials 2012; 33: 1596–606
   PubMed Web of Science ®Google Scholar
• Kumar A, Jena PK, Behera S, Lockey RF, Mohapatra S, Mohapatra S. Multifunctional magnetic nanoparticles for targeted delivery. Nanomed Nanotechnol Biol Med 2010; 6: 64–9
   PubMed Web of Science ®Google Scholar
• Lindner LH, Hossann M. Factors affecting drug release from liposomes. Curr Opin Drug Discov Devel 2010; 13: 111–23
   PubMed Web of Science ®Google Scholar
• Liu SL, Zhang LN, Zhou JP, Wu RX. Structure and properties of cellulose/Fe2O3 nanocomposite fibers spun via an effective pathway. J Phys Chem C 2008; 112: 4538–44
   Web of Science ®Google Scholar
• Matsingou C, Demetzos C. Calorimetric study on the induction of interdigitated phase in hydrated DPPC bilayers by bioactive labdanes and correlation to their liposome stability: The role of chemical structure. Chem Phys Lipids 2007; 145: 45–62
   PubMed Web of Science ®Google Scholar
• Mitsudomi T, Morita S, Yatabe Y, Negoro S, Okamoto I, Tsurutani J, Seto T, Satouchi M, Tada H, Hirashima T, et al. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): An open label, randomised phase 3 trial. Lancet Oncol 2010; 11: 121–8
   PubMed Web of Science ®Google Scholar
• Mohammed AR, Bramwell VW, Kirby DJ, McNeil SE, Perrie Y. Increased potential of a cationic liposome-based delivery system: Enhancing stability and sustained immunological activity in preclinical development. Eur J Pharm Biopharm 2010; 76: 404–12
   PubMed Web of Science ®Google Scholar
• Neumann MG, Schmitt CC, Iamazaki ET. A fluorescence study of the interactions between sodium alginate and surfactants. Permissions Reprints 2003; 338: 1109–13
   Google Scholar
• Pankhurst QA, Thanh NKT, Jones SK, Dobson J. Progress in applications of magnetic nanoparticles in biomedicine. J Phys D: Appl Phys 2009; 42: 224001(15pp)
   Google Scholar
• Qu J, Li X, Wang J, Mi WJ, Xie KL, Qiu JH. Inhalation of hydrogen gas attenuates cisplatin-induced ototoxicity via reducing oxidative stress. IJPORL 2012; 76: 111–5
   Google Scholar
• Rosell R, Gatzemeier U, Betticher DC, Keppler U, Macha HN, Pirker R, Berthet P, Breau JL, Lianes P, Nicholson M, et al. Phase III randomised trial comparing aclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced on-small-cell lung cancer: A cooperative multinational trial. Ann Oncol 2002; 13: 1539–49
   PubMed Web of Science ®Google Scholar
• Sastry J, Kellie SJ. Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine. Pediatr Hematol Oncol 2005; 22: 441–5
   PubMed Web of Science ®Google Scholar
• Si SF, Li CH, Wang X, Yu D, Peng Q, Li YD. Magnetic monodisperse Fe3O4 nanoparticles. Cryst Growth Des 2005; 5: 391–3
   Web of Science ®Google Scholar
• Tagami T, Ernsting MJ, Li SD. Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system. J Control Release 2011; 154: 290–7
   PubMed Web of Science ®Google Scholar
• Thakkar VT, Shah PA, Soni TG, Parmar MY, Gohel MC, Gandhi TR. Goodness-of-fit model-dependent approach for release kinetics of levofloxacin hemihydrates floating tablet. Dissolut Technol 2009; 2: 35–9
   Google Scholar
• Wang HJ, Zhang ShN, Liao ZhY, Wang ChY, Liu Y, Feng ShQ, Jiang XG, Chang J. PEGlated magnetic polymeric liposome anchored with TAT for delivery of drugs across the blood-spinal cordbarrier. Biomaterials 2010; 31: 6589–96
   PubMed Web of Science ®Google Scholar
• Wu JH, Ko SP, Liu HL, Jung MH, Lee JH, Ju JS, Kimb YK. Sub 5 nm Fe3O4 nanocrystals via coprecipitation method. Colloids Surf A: Physicochem Eng Asp 2008; 313–314: 268–72
   Google Scholar
• Xiao C, Qi X, Maitani Y, Nagai T. Sustained release of cisplatin from multivesicular liposomes: Potentiation of antitumor efficacy against S180 murine carcinoma. J Pharm Sci 2004; 93: 18–24
   Google Scholar
• Ziyad SH, Reggie CH, Maryam T. Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes. Biomaterials 2008; 29: 1207–15
   PubMedGoogle Scholar